Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir/Lopinavir/Ritonavir vs HCQ/Ivermectin in COVID-19
NCT04779047Phase 4Unknown
- Sponsor
- October 6 University
- Start
- Oct 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of remdesivir, lopinavir, ritonavir, hydroxychloroquine, ivermectin in coronavirus disease 2019 (COVID-19), sponsored by October 6 University. Status: unknown.
02
Drugs
remdesivirlopinavirritonavirhydroxychloroquineivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04779047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779047.